Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(38%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_1
1
13%
Ph phase_2
2
25%
Ph early_phase_1
1
13%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(2)
Other(2)

Detailed Status

unknown2
Recruiting2
Completed2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 22 (28.6%)
N/A3 (42.9%)

Trials by Status

unknown225%
not_yet_recruiting113%
recruiting225%
completed225%
active_not_recruiting113%

Recent Activity

3 active trials
Showing 5 of 8
not_yet_recruitingphase_1

PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention

NCT07449247
completedphase_2

Low-dose Atropine for the Prevention of Myopia Progression in Danish Children

NCT03911271
active_not_recruitingphase_2

Early Intervention for Premyopic Children

NCT06200194
recruitingnot_applicable

Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

NCT06667037
recruitingnot_applicable

Electronic Spectacles Versus Low Dose Atropine in Young Myopes

NCT06034379
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07449247Phase 1

PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention

Not Yet Recruiting
NCT03911271Phase 2

Low-dose Atropine for the Prevention of Myopia Progression in Danish Children

Completed
NCT06200194Phase 2

Early Intervention for Premyopic Children

Active Not Recruiting
NCT06667037Not Applicable

Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

Recruiting
NCT06034379Not Applicable

Electronic Spectacles Versus Low Dose Atropine in Young Myopes

Recruiting
NCT06034366Not Applicable

the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression

Unknown
NCT05199597Early Phase 1

The Response to Atropine Drops (RAD) Study

Completed
NCT05090592

Influence of Corneal Biomechanical Properties on Myopia Control

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8